businessNewsغير مصنف

Trump drug cost comments raise new risks for pharma stocks

NEW YORK (Reuters) – Comments from Republican presidential front-runner Donald Trump that Medicare could reap huge savings by negotiating with drugmakers raise new risks for the biotech and pharmaceutical industries, whose shares have been pressured by criticism from Democrats.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى